Breaking News, Collaborations & Alliances

Grünenthal, Kyowa Kirin International Enter Joint Venture Collaboration

Includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines.

Grünenthal GmbH, a global, science-based pharmaceutical company and Kyowa Kirin Co., Ltd., a Japan-based global specialty pharmaceutical company, have completed a deal to enter into a joint venture collaboration for Kyowa Kirin International’s established medicines portfolio. The portfolio comprises 13 brands across six therapeutic areas primarily focused on pain management, including Abstral and PecFent for breakthrough cancer pain, Moventig for opioid-induced constipation, and Adcal-D...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters